Ask AI
ProCE Banner Events

Share

Updates in Metastatic Prostate Cancer: Guidance for the Multidisciplinary Team and VA Systems [Open Registration]

Join us for this live 1-hour, CME/CE/CPE-certified workshop series to learn how healthcare professionals in the community and Veterans Affairs can effectively incorporate newly approved and emerging treatment regimens into the care of patients with metastatic prostate cancer.

Nurse Practitioners/Nurses: 1.00 Nursing contact hour

Pharmacists: 1.00 contact hour (0.1 CEUs)

Physicians: maximum of 1.00 AMA PRA Category 1 Credit

This event has expired. No longer available for credits.

Credits Available

1.0

Who Should Attend

Oncologists, nurses, pharmacists, and other healthcare professionals on the multidisciplinary team caring for patients with prostate cancer.

Time and location

Wednesday, May 24, 2023

4:30 PM - 5:30 PM Central Time (CT)

Virtual

CCO Simulcast | Host Group OK
Norman, Oklahoma

Faculty
Daniel P. Petrylak, MD

Associate Professor of Medicine
Columbia Presbyterian Medical Center
Director, Genitourinary Oncology Program
Division of Medical Oncology
Columbia University College of Physicians and Surgeons
New York, New York

Agenda

  • Welcome, Introduction, and Baseline Assessment
  • Individualizing Treatment in Prostate Cancer
  • Integrating Patient Preferences
  • Clinical Pearls/Applications: Prostate Cancer Care and Evolution

Location

Venue Name

CCO Simulcast | Host Group OK

Address

CCO Simulcast | Host Group OK
Norman, Oklahoma

CME/CE Info

Goal Statement
The goal of this activity is to improve learners’ knowledge, competence, and performance in applying practice-changing clinical data and expert recommendations to integrate the use of currently available therapies for their patients with metastatic prostate cancer.

Target Audience
This program is intended for oncologists, nurses, pharmacists, and other healthcare professionals on the multidisciplinary team caring for patients with prostate cancer. 

Learning Objectives
Upon completion of this activity, participants should be able to:

  • Evaluate novel therapeutically actionable molecular targets that hold promise as predictive or prognostic biomarkers for patients with metastatic prostate cancer
  • Plan optimal, individualized sequential therapeutic strategies for metastatic prostate cancer, considering all available agents, clinical data including novel imaging techniques, and expert recommendations
  • Counsel patients with metastatic prostate cancer on available therapies, taking into consideration patient preferences regarding differences in administration and safety profiles, as well as comorbidities and patient goals
  • Identify patients with metastatic prostate cancer who may be eligible for enrollment on ongoing clinical studies investigating novel regimens

Accreditation

Joint Accreditation Statement

In support of improving patient care, Clinical Care Options, LLC (CCO) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physician Continuing Medical Education

Designation of Credit

CCO designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nursing Continuing Professional Development
The maximum number of hours awarded for this Nursing Continuing Professional Development activity is 1.0 contact hour. 

Continuing Pharmacy Education

CCO designates this continuing education activity for 1.0 contact hour (0.1 CEUs) of the Accreditation Council for Pharmacy Education. Universal Activity Number: JA4008176-0000-23-022-L01-P.

Type of Activity: Application

Upon successfully completing the activity evaluation form, transcript information will be sent to the NABP CPE Monitor Service within 60 days.

Disclosure of Conflicts of Interest 
In support of improving patient care, Clinical Care Options, LLC (CCO) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Acknowledgement

Provided by Clinical Care Options, LLC.

Supported by educational grants from Astellas, AstraZeneca Pharmaceuticals, Bayer HealthCare Pharmaceuticals Inc., Merck Sharp & Dohme Corp., and Sanofi Genzyme.

Contact Information

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address:

 

Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Additional Information

There are no fees required to participate in this activity.

Americans With Disabilities Act
Event staff will be glad to assist you with any special needs (eg, physical, dietary). Please contact meetings@clinicaloptions.com prior to the live event.